Drug Repurposing for Rare Diseases 2022

The drug repurposing field has shifted after stepping into the limelight during the global COVID-19 pandemic. The world is beginning to care about drug repurposing and is recognising the opportunities to repurpose a drug to treat an often rare and neglected condition.

Repurposing schemes, projects and ideas are all in place to accelerate access to desperately needed medicines - the answers have been right under our noses all along!

At Drug Repurposing for Rare Diseases 2022, Beacon is shifting its programme to match the new drug repurposing landscape; one that’s filled with hope, promise and innovation. Instead of inspiring attendees with case studies on how you could succeed with a repurposing project, they’re taking a more active approach by sharing how you can take your repurposing project to the next level.

Beacon has seen numerous projects come to the forefront that have drastically changed the repurposing landscape. These projects are making a measurable difference in the lives of patients. Structural changes have been introduced to improve how the scientific community approaches drug repurposing projects. Every innovation is advancing repurposing projects in a meaningful, patient-centric way.

Beacon’s programme will highlight those who dared to believe in drug repurposing and are bringing repurposed medicines to patients at an accelerated rate. Be sure to register for #DrugRepo22 to hear from:

• The Centre for Drug Development, Cancer Research UK
• MHRA
• LifeArc
• NHS England and NHS Improvement
• REMEDi4ALL
• Liverpool School of Tropical Medicine
• National Alkaptonuria Centre
• And more!

Gain the tools, connections and ways needed to bring your repurposing project to the forefront at #DrugRepo22. Beacon’s conference will help you deliver your repurposing project, so others can look to you as a beacon of hope.

Register to attend now and join the community on 10th October in London!